NB

Naga Bhushanam Muppala

Active Director Director DIN 01907135
DIN 01907135 First appointment Dec 1998 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 1998
Shareholding value •••• Premium profile

About Naga Bhushanam Muppala

Data last updated:

Naga Bhushanam Muppala is a Director at Indian Genomix Private Limited (since 1998). The company operates in Pharma. Indian Genomix Private Limited reported revenue of ₹23.72 Cr (FY 2025).

DIN 01907135
Primary Designation Director
Industry Pharma
First Appointment 23 Dec 1998
Oldest Company Age 27 yrs
Largest company Indian Genomix Private Limited · ₹23.72 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Indian Genomix Private Limited U24230TG1998PTC030757
Director23 Dec 19981998₹23.72 Cr (FY 2025)Active

Board colleagues of Naga Bhushanam Muppala

NameDINCompanyDesignation
Anil Kumar Muppala00987994Indian Genomix Private LimitedDirector

Directorship timeline

Open interactive timeline →
Indian Genomix Private Limited
Premium access

Shareholding and investment profile for Naga Bhushanam Muppala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naga Bhushanam Muppala

Naga Bhushanam Muppala currently holds 1 directorship: Indian Genomix Private Limited (Director, since 23 Dec 1998, revenue ₹23.72 Cr (FY 2025)).

Naga Bhushanam Muppala was first appointed on 23 Dec 1998 as Director at Indian Genomix Private Limited.

The current boards of Naga Bhushanam Muppala's companies include Anil Kumar Muppala (Indian Genomix Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available